Information
-
Trademark
-
88404359
-
Serial Number
88404359
-
Registration Number
6077767
-
International Classifications
-
Filing Date
April 26, 2019
5 years ago
-
Registration Date
June 16, 2020
4 years ago
-
Transaction Date
June 16, 2020
4 years ago
-
Status Date
June 16, 2020
4 years ago
-
Published for Opposition Date
March 31, 2020
4 years ago
-
Location Date
June 16, 2020
4 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
IM, JEAN H
-
Attorney Docket Number
07626-T0001A
Attorney Name
Stephen P. McNamara
Law Office Assigned Location Code
L10
-
Owners
Mark Drawing Code
4000
Mark Identification
MEDINCELL
Case File Statements
- GS0051: Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders
Case File Event Statements
-
6/16/2020 - 4 years ago
23 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
3/31/2020 - 4 years ago
22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/31/2020 - 4 years ago
21 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
3/11/2020 - 4 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
2/27/2020 - 4 years ago
19 - ELECTRONIC RECORD REVIEW COMPLETE
Type: FIXD
-
2/7/2020 - 5 years ago
18 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Type: ERRR
-
1/31/2020 - 5 years ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
1/31/2020 - 5 years ago
16 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
1/31/2020 - 5 years ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
1/31/2020 - 5 years ago
14 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
1/31/2020 - 5 years ago
13 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
1/9/2020 - 5 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
1/8/2020 - 5 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/8/2020 - 5 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/10/2019 - 5 years ago
9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
7/10/2019 - 5 years ago
8 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/10/2019 - 5 years ago
7 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/9/2019 - 5 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/23/2019 - 5 years ago
5 - APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED
Type: AMPX
-
5/19/2019 - 5 years ago
4 - ASSIGNED TO LIE
Type: ALIE
-
5/13/2019 - 5 years ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
5/13/2019 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
4/30/2019 - 5 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP